Biological role of phosphatase PTEN in cancer and tissue injury healing

被引:34
作者
Tsugawa, K
Jones, MK
Sugimachi, K
Sarfeh, IJ
Tarnawski, AS
机构
[1] Dept Vet Affairs Med Ctr, Dept Med, Gastroenterol Sect 111G, Long Beach, CA 90822 USA
[2] Dept Vet Affairs Med Ctr, Dept Surg, Long Beach, CA 90822 USA
[3] Univ Calif Irvine, Irvine, CA USA
[4] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2002年 / 7卷
关键词
PTEN; tissue injury healing; cancer; angiogenesis; cell proliferation; cell survival; cell migration; apoptosis; Review;
D O I
10.2741/tsugawa
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PTEN (phosphatas and tensin homolog deleted on chromosome ten) also referred to as MMAC (mutated in multiple advanced cancers) was discovered as a tumor suppressor gene and later found to be a phospholipid phosphatas. PTEN negatively regulates Akt activation by preventing its phosphorylation. PTEN there fore inhibits the PI 3-kinas/Akt signaling pathway which is important for cell growth and survival. Overexpression or enhanced activation of PTEN can potentially impair injury healing by at least 4 mechanisms. PTEN can: 1) inhibit entry into the cell cycle by inhibiting G1 to S phase progression and arrest cell proliferation required for tissue reconstruction during injury h aling; 2) incr as apoptosis by blocking Akt activation leading to increased Bad and Caspase- 9 activities; 3) inhibit hypoxia-induced angiogenesis required for injury healing by blocking Akt-mediated VEGF gene transcription; 4) inhibit Akt-mediated cell migration, i.e. re-epithelialization, which is also required for injury healing. The same mechanisms can also suppress cancer growth and metastases. Therefore, elucidating the role of the PTEN/PI 3-kinase/Akt pathway will likely advance our knowledge of the mechanisms controlling the processes of injury healing and cancer growth.
引用
收藏
页码:E245 / E251
页数:7
相关论文
共 44 条
  • [1] PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
    Besson, A
    Robbins, SM
    Yong, VW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03): : 605 - 611
  • [2] Boström J, 1998, CANCER RES, V58, P29
  • [3] Cairns P, 1997, CANCER RES, V57, P4997
  • [4] New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway
    Cantley, LC
    Neel, BG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) : 4240 - 4245
  • [5] Chen JD, 1998, HUM GENET, V102, P124
  • [6] Dahia PLM, 1997, CANCER RES, V57, P4710
  • [7] The multiple roles of PTEN in tumor suppression
    Di Cristofano, A
    Pandolfi, PP
    [J]. CELL, 2000, 100 (04) : 387 - 390
  • [8] Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
    Graff, JR
    Konicek, BW
    McNulty, AM
    Wang, ZJ
    Houck, K
    Allen, S
    Paul, JD
    Hbaiu, A
    Goode, RG
    Sandusky, GE
    Vessella, RL
    Neubauer, BL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24500 - 24505
  • [9] Guldberg P, 1997, CANCER RES, V57, P3660
  • [10] HUANG J, 2002, UNPUB J BIOL CH 0109